Healthcare Industry News: Automated External Defibrillator
News Release - September 11, 2008
FDA Classifies as a Class I Action an Urgent Medical Device Correction by Physio-Control
A limited number of LIFEPAK CR(R) Plus Automated External Defibrillators are AffectedMINNEAPOLIS--(HSMN NewsFeed)--Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT ) announced today the FDA has classified as a Class I action the company’s recently initiated and completed voluntary urgent medical device recall of 249 fully automatic LIFEPAK CR Plus Automated External Defibrillators (AEDs). Certain fully automated devices manufactured from May 2004 through April 2007 are mis-configured with the software intended for semi-automatic AEDs. With this configuration set up, if the responder is instructed to press the shock button to deliver therapy, they will not be able to locate the shock button because it is covered in the fully automated device. In this situation, it is possible that therapy could be delayed or not delivered at all; possibly resulting in death. There has been one patient related complaint associated with this issue.
As of September 2, 2008, the company has notified all affected customers and shipped replacement devices at no charge. During the brief interval while customers awaited receipt of replacement devices, Physio-Control recommended that customers with the identified, affected defibrillators either remove the affected AED(s) from service or remove and discard the shock button cover (instructions provided).
If customers have questions or would like additional information they should contact Physio-Control Technical Support. Customers may also visit the company’s website at www.physio-control-notices.com/config for more information or to enter the serial numbers of their devices to determine if they are affected by this action.
About the LIFEPAK CR Plus AEDs
The LIFEPAK CR Plus Automated External Defibrillators (AEDs) are battery operated and portable. These AEDs are placed in public access environments such as schools, airports, city halls, retail locations and workplaces. Anyone with minimal CPR/AED training can use an AED to provide a defibrillation shock to someone in sudden cardiac arrest.
About Physio-Control
Physio-Control is located in Redmond, Wash. Physio-Control pioneered defibrillation technology over 50 years ago. Withmore than 650,000 LIFEPAK® defibrillators distributed worldwide, the company is the world’s leading provider of external defibrillators for the treatment of sudden cardiac arrest. To find out more about Physio-Control, go to www.physio-control.com or call 1-800-442-1142.
Source: Medtronic
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
Related News Items
Medtronic appoints Thierry Piéton as Chief Financial OfficerMedtronic Achieves CE Mark Approval for BrainSense Adaptive Deep Brain Stimulation and Electrode Identifier, a Groundbreaking Advance In Personalized, Sensing-Enabled Care for People with Parkinson's Through Innovative Brain-Computer Interface Technology
Medtronic Receives FDA Clearance for New InPen(TM) App, Paving the Way for its Smart MDI System Launch with Simplera(TM) CGM
